mRNA & Gene Editing – Delineating the Convergence of mRNA’s Potential as a Tool to Treat Genetic Diseases
Time: 12:45 pm
day: mRNA Technology & Innovation Day
Details:
With the UK approval of the world’s first gene-editing treatment for blood cancer, the race is now on to develop next-generation gene editing technologies leveraging mRNA technology with the mission to develop curative therapies for some of the most challenging genetic diseases.
With a convergence of academic and industry collaborations to focus on bringing these drugs to patients with minimal toxicity and affordability, this workshop will deep-dive into novel gene editing technology and delivery with the mRNA payload at center focus to truly unlock future applications of this technology.
Case-Study Examples Include:
- Unleashing RNA-based gene editing and delivery to minimize toxic effects for improved therapies
- Achieving low-cost mRNA-based gene therapies for retinal diseases
